-+ 0.00%
-+ 0.00%
-+ 0.00%

MGC Diagnostics cites ERS 2026 trial showing laughter therapy reduces breathlessness in COPD patients

PUBT·10/06/2026 16:20:14
Listen to the news
MGC Diagnostics cites ERS 2026 trial showing laughter therapy reduces breathlessness in COPD patients
  • MGC Diagnostics flagged new COPD research results presented at the ERS Congress 2026 in Barcelona.
  • A randomized trial in Türkiye tested structured laughter exercises versus pursed-lip breathing or usual care in 63 patients.
  • The laughter-therapy group reported less breathlessness versus the control group, with improved health-related quality of life.
  • Benefits persisted for at least a month post-intervention, though authors framed findings as preliminary pending larger studies.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MGC Diagnostics Corporation published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.